Tariff classification of medicinal silicones denied exemption where Item 68 applied only to goods not elsewhere specified.

The classification of Dimethicone and Simethicone turned on whether medicinal use could take silicones out of Tariff Item 15A and place them in residuary Item 68 for exemption. The Court treated the excise scheme as covering all excisable goods, with Item 68 confined to goods not elsewhere specified, and held that the exemption notifications applied only to goods already falling within Item 68 as bulk drugs, medicines or drug-intermediates. As the products were silicones in primary form, there was no sustainable basis to separate industrial and medicinal silicone for tariff purposes. The Revenue's classification was upheld and exemption was denied.

---

---

Issues: Whether the medicinal silicone products Dimethicone and Simethicone were classifiable under Tariff Item 15A or could be treated as goods not elsewhere specified under Tariff Item 68 so as to claim exemption under the relevant notifications.

Analysis: The levy under Section 3 of the Central Excises and Salt Act, 1944 operated on all excisable goods, with Items 1 to 67 covering specified goods and Item 68 serving as the residuary entry. The exemption notifications applied only to goods falling under Item 68 and described as bulk drugs, medicines and drug-intermediates not elsewhere specified. The products in question were found to be silicones in primary form, and the Court held that there was no legally sustainable basis to split silicone into industrial and medicinal forms for the purpose of taking it out of Item 15A. The language of the notifications was treated as controlling, and exemption was confined to goods already falling within Item 68.

Conclusion: The products did not qualify for exemption under the notifications and were not entitled to be treated as goods under Item 68 for that purpose; the classification adopted by the Revenue was upheld.

---